Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$3,000.00
Jun 5, 2019
For-profit organization
Participation in the partnering mission to the Canada-Germany Medical Cannabis Network – June 17-19, 2019
929835
Participation in the Canadian partnering mission to the Canada -Germany Medical Cannabis Network - June 17-19, 2019 delegation, led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop international partnerships and potential project ideas under the IRAP – ZIM international networks.
$160,000.00
Jul 17, 2017
$160,000.00
Jul 3, 2017
For-profit organization
Development of new cannabinoid pharmaceuticals
890777
Development of improved cannabionoid pharmaceutical products with more convenient routes of administration and/or improved pharmacokinetic profiles.